I am particularly concerned--and I am sure my colleagues have received all sorts of correspondence on what is happening with drug manufacturers--the recent EpiPen situation, where you have a drug that really has not changed much in years, as far as its composition, and, yet, we have seen a 400-percent cost increase by the drug company.
Peters highlights concerns over significant price increases in drugs like EpiPen without changes in composition.
Share & report
More from Gary Peters
Mr. President, shortly, I will ask for unanimous consent to confirm Rahkel Bouchet and John Truong to be associate judges for the District of Columbia Superior Court. The DC Superior Court functions as the State-level trial court in the…
Madam President, I rise in support of David Huitema's nomination to be the Director of the Office of Government Ethics. This Office leads and oversees the executive branch ethics program on behalf of the American people and is at work in…
Mr. Speaker, our national debt is more than $36 trillion. We borrow nearly $2 trillion every year just to pay our expenses. We spend more in interest payments now than we do on Medicaid, schools, childcare, and the national defense…
Mr. President, I rise in opposition to the nomination of former Representative Tulsi Gabbard to serve as our Nation's Director of National Intelligence. Intelligence is absolutely fundamental to our national security. Our intelligence…
Other voices in this conversation
